Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2012
02/21/2012US8119117 Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity
02/21/2012US8119114 Polymer conjugates of mutated neublastin
02/21/2012CA2634173C Plants with reduced expression of phosphatase type 2c gene for enhanced pathogen resistance
02/21/2012CA2568995C Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
02/21/2012CA2534585C Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
02/21/2012CA2506247C Novel aldolase, and method for producing optically active ihog and monatin
02/21/2012CA2487116C Fermentation process using specific oxygen uptake rates as a process control
02/21/2012CA2482097C Methods for isolating nucleic acids
02/21/2012CA2447033C Phosphotriesterase from agrobacterium radiobacter p230
02/21/2012CA2420413C Plant polynucleotides encoding novel vacuolar na+/h+ antiporters
02/21/2012CA2418962C Anti-dual integrin antibodies, compositions, methods and uses
02/21/2012CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein
02/21/2012CA2409983C Viral variants and methods of using same
02/21/2012CA2407680C Dendritic cell co-stimulator molecules
02/21/2012CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
02/21/2012CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
02/21/2012CA2353698C Human hybrid host cell for mammalian gene expression
02/21/2012CA2351593C Polymer grafting by polysaccharide synthases
02/21/2012CA2350185C Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla
02/21/2012CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors
02/21/2012CA2338250C Lafora's disease gene
02/21/2012CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
02/21/2012CA2321934C Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
02/21/2012CA2302866C Genetically modified tumor-targeted bacteria with reduced virulence
02/21/2012CA2297303C Novel peptides and polypeptides useful for regenerating the nervous system
02/21/2012CA2296841C Tropoelastin derivatives
02/21/2012CA2269085C Rainbow trout il1.beta.; encoding nucleic acid; materials and methods
02/21/2012CA2264592C Bioconjugates and delivery of bioactive agents
02/21/2012CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome
02/21/2012CA2230759C Chimeric animal and method for producing the same
02/21/2012CA2158936C Compositions and methods for utilizing conditionally lethal genes
02/18/2012CA2808265A1 Solution for extraction of rna
02/16/2012WO2012021803A1 Method for using ref protein as a targeted reca-dependent nuclease
02/16/2012WO2012021797A1 Methods and compositions for targeting sequences of interest to the chloroplast
02/16/2012WO2012021794A1 Chimeric promoters and methods of use
02/16/2012WO2012021785A1 Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity
02/16/2012WO2012021632A2 Generation and use of pluripotent stem cells
02/16/2012WO2012021558A1 Methods and compositions for preventing a condition
02/16/2012WO2012021554A1 Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
02/16/2012WO2012021500A2 Antipathogenic proteins and methods of use
02/16/2012WO2012021494A1 Method for gene delivery into grain legumes and in vitro regeneration of same
02/16/2012WO2012021054A2 A diagnostic system for malaria
02/16/2012WO2012020965A2 Pik3ca mutation detection method and kit using real-time pcr clamping of pna
02/16/2012WO2012020871A1 Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer
02/16/2012WO2012020843A1 Transgenic animal, transformed stem cell, and use thereof
02/16/2012WO2012020842A1 Complex having tumor vaccine effect, and use thereof
02/16/2012WO2012020839A1 Pharmaceutical composition for cancer therapy
02/16/2012WO2012020836A1 Therapeutic agent for hepatitis c containing rrm2 antagonist as active ingredient
02/16/2012WO2012020833A1 Isopropyl alcohol-producing bacterium having improved productivity by gntr destruction
02/16/2012WO2012020795A1 Nucleic acid/polysaccharide complex
02/16/2012WO2012020759A1 Variant reverse transcriptase
02/16/2012WO2012020679A1 Method and test piece for simultaneously typing influenza virus a and detecting oseltamivir phosphate-resistant mutation
02/16/2012WO2012020622A1 Fragment of humanized anti-egfr antibody substituted-lysine variable fragment and use thereof
02/16/2012WO2012020574A1 Heterologous expression of fungal polyketide synthetic gene in yeast
02/16/2012WO2012020566A1 Highly functionalized stem cell/progenitor cell by ape1 gene transfection
02/16/2012WO2012020230A1 Polymer particle
02/16/2012WO2012020143A1 Improved anti-serum albumin binding variants
02/16/2012WO2012020072A1 Anti-syndecan-4 antibodies
02/16/2012WO2012020040A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions
02/16/2012WO2012020001A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
02/16/2012WO2012019991A1 Methods and pharmaceutical compositions for the treatment of hiv-1 infections
02/16/2012WO2012019928A1 Modified peptide display
02/16/2012WO2012019780A1 Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
02/16/2012WO2012019765A1 Methods and systems for tracking samples and sample combinations
02/16/2012WO2012019660A1 Process of transfecting plants
02/16/2012WO2012019630A1 Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
02/16/2012WO2012019619A1 Fluorescent proteins with increased activity in cells
02/16/2012WO2012019326A1 An agrobacterium tumefaciens-mediated gene transformation method for jatropha curcas
02/16/2012WO2012019260A2 A synthetic rna molecule of the hepatitis c virus, production method of same and use thereof as an internal control for the quantification and/or identification of the hepatitis c virus
02/16/2012WO2012003207A3 Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding pae and pae-like polypeptides
02/16/2012WO2011161460A3 Rna molecules and uses thereof
02/16/2012WO2011159153A3 Inducible promoter and its use
02/16/2012WO2011156619A3 Vaccine and methods to reduce campylobacter infection
02/16/2012WO2011155833A3 Combinatorial sequence barcodes for high throughput screening
02/16/2012WO2011154927A3 Direct cloning
02/16/2012WO2011154553A3 Micrornas for the detection and isolation of human embryonic stem cell -derived cardiacv cell types
02/16/2012WO2011131693A3 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
02/16/2012WO2011121456A3 Nucleic acids and protein sequences of costunolide synthase
02/16/2012WO2011116014A9 Humanized antibodies to labyrinthin and uses thereof
02/16/2012WO2011112880A3 Hypermethylation biomarkers for detection of head and neck squamous cell cancer
02/16/2012WO2011109104A3 Molecular clone of hiv-1
02/16/2012WO2011091419A3 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
02/16/2012WO2010107740A8 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
02/16/2012WO2002085309A9 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
02/16/2012US20120042421 Perilla-derived promoter functioning in petals
02/16/2012US20120042418 Engineering NF-YB Transcription Factors for Enhanced Drought Resistance and Increased Yield in Transgenic Plants
02/16/2012US20120042417 Enhanced accumulation of carotenoids in plants
02/16/2012US20120042416 Antibody fusion-mediated plant resistance against Oomycota
02/16/2012US20120042415 Transgenic plants expressing l3 delta proteins are resistant to trichothecene fungal toxins
02/16/2012US20120042414 Chimeric promoters and methods of use
02/16/2012US20120042413 Compositions And Methods Comprising Sequences Having Hydroxyphenylpyruvate Dioxygenase (HPPD) Activity
02/16/2012US20120042412 Methods And Compositions For Targeting Sequences Of Interest To The Chloroplast
02/16/2012US20120042411 Gene targeting in plants
02/16/2012US20120042410 Abscisic acid carrier gene and transgenic plant expressing the same
02/16/2012US20120042409 Plant transformation using dna minicircles
02/16/2012US20120042408 Plants producing 2n gametes or apomeiotic gametes
02/16/2012US20120042406 Lettuce Cultivar Danielle
02/16/2012US20120042405 Lettuce Cultivar Jeanine
02/16/2012US20120042403 Cucumber Hybrid Enki
02/16/2012US20120042402 Cucumber Hybrid Menfis
1 ... 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 ... 4023